diloxanide furoate has been researched along with furazolidone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fawzy, AF; Khalil, HM; Sarwat, MA | 1 |
| Wolfe, MS | 1 |
| Hosseini, J; Swan, JC; Zierdt, CH | 1 |
| Parimoo, P; Prasad, CV; Saha, RN; Sripriya, V | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 review(s) available for diloxanide furoate and furazolidone
| Article | Year |
|---|---|
The treatment of intestinal protozoan infections.
Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoebiasis; Drug Combinations; Dysentery, Amebic; Emetine; Furans; Furazolidone; Giardiasis; Humans; Intestinal Diseases, Parasitic; Iodoquinol; Liver Abscess, Amebic; Metronidazole; Paromomycin; Quinacrine; Sulfamethoxazole; Tetracycline; Tinidazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
4 other study(ies) available for diloxanide furoate and furazolidone
| Article | Year |
|---|---|
Trials of furazol and some other drugs in intestinal amoebiasis.
Topics: Amebicides; Dysentery, Amebic; Furans; Furazolidone; Humans; Iodoquinol; Metronidazole; Tinidazole | 1987 |
In vitro response of Blastocystis hominis to antiprotozoal drugs.
Topics: Animals; Antiprotozoal Agents; Emetine; Eukaryota; Furans; Furazolidone; Metronidazole; Paromomycin; Pentamidine; Quinolines; Sulfamethoxazole; Trimethoprim | 1983 |
Simultaneous determination of tinidazole, furazolidone and diloxanide furoate in a combined tablet preparation by second-derivative spectrophotometry.
Topics: Antiprotozoal Agents; Drug Combinations; Furans; Furazolidone; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets; Tinidazole | 1999 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |